Skip to main content
Signal8
Andrews Patricia S profile photo

Patricia S. Andrews

CIK: 0001445710

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ONCOLYTICS BIOTECH INC logo
ONCY

ONCOLYTICS BIOTECH INC

Director
GERON CORP logo
GERN

GERON CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Jun 1, 2026
    Award(A)

    Stock Option

    Direct
    30K shares-
  • GERON CORP logo
    GERN

    GERON CORP

    Mar 25, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    270K shares-
  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Feb 12, 2026
    Purchase(P)
    Direct
    35.4K shares at avg. $0.86$30K

1-3 of 3

About Andrews Patricia S

Andrews Patricia S (SEC CIK 0001445710) files insider reports with the SEC as Director of ONCOLYTICS BIOTECH INC (ONCY) and Director of GERON CORP (GERN).

Signal8 holds 5 ownership filings by Andrews Patricia S (2 Form 3, 3 Form 4), filed between Jan 2, 2026 and Jun 3, 2026. Those filings report 3 transactions, from Feb 12, 2026 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Andrews Patricia S's filings is in SAN DIEGO, CA.

Recent filings by Andrews Patricia S

  • Jun 1, 2026: Grant or award of ONCY derivative securities (Form 4, code A).
  • Mar 25, 2026: Grant or award of GERN derivative securities (Form 4, code A).
  • Feb 12, 2026: Open-market purchase of ONCY shares (Form 4, code P).

Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)

How to read Form 4 transaction codes